Loading...
TherapeuticsMD, Inc.
TXMD•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.09
$0.01(0.93%)
TherapeuticsMD, Inc. (TXMD) Financial Performance & Statements
Review TherapeuticsMD, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
35.25%
↑ 35.25%
Operating Income Growth
44.15%
↑ 44.15%
Net Income Growth
78.78%
↑ 78.78%
Operating Cash Flow Growth
102.43%
↑ 102.43%
Operating Margin
-310.01%
↓ 310.01%
Gross Margin
93.09%
↑ 93.09%
Net Profit Margin
-145.03%
↓ 145.03%
ROE
-7.72%
↓ 7.72%
ROIC
-13.40%
↓ 13.40%
TherapeuticsMD, Inc. (TXMD) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for TherapeuticsMD, Inc. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $667000.00 | $547000.00 | $234000.00 | $313000.00 |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $133000.00 |
| Gross Profit | $667000.00 | $547000.00 | $234000.00 | $180000.00 |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $0.58 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $879000.00 | $1.31M | $1.23M | $1.32M |
| Operating Expenses | $986000.00 | $1.41M | $2.67M | $1.32M |
| Total Costs & Expenses | $986000.00 | $1.41M | $2.67M | $1.46M |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $3000.00 | $5000.00 | $0.00 |
| Depreciation & Amortization | $100000.00 | $96000.00 | $180000.00 | $133000.00 |
| EBITDA | -$974000.00 | -$474000.00 | -$865000.00 | -$676000.00 |
| EBITDA Ratio | -$1.46 | -$0.87 | -$3.70 | -$2.16 |
| Operating Income | -$319000.00 | -$859000.00 | -$2.44M | -$1.14M |
| Operating Income Ratio | -$0.48 | -$1.57 | -$10.43 | -$3.65 |
| Other Income/Expenses (Net) | $402000.00 | $292000.00 | $1.39M | $333000.00 |
| Income Before Tax | $83000.00 | -$567000.00 | -$1.05M | -$809000.00 |
| Income Before Tax Ratio | $0.12 | -$1.04 | -$4.49 | -$2.58 |
| Income Tax Expense | -$31000.00 | $0.00 | $0.00 | -$75000.00 |
| Net Income | $252000.00 | -$609000.00 | -$1.09M | -$734000.00 |
| Net Income Ratio | $0.38 | -$1.11 | -$4.66 | -$2.35 |
| EPS | $0.00 | -$0.05 | -$0.09 | -$0.06 |
| Diluted EPS | $0.00 | -$0.05 | -$0.09 | -$0.06 |
| Weighted Avg Shares Outstanding | $11.53M | $11.53M | $11.53M | $11.53M |
| Weighted Avg Shares Outstanding (Diluted) | $11.53M | $11.53M | $11.53M | $11.53M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan